125 related articles for article (PubMed ID: 15738532)
1. Treatment of chronic lymphocytic leukemia: achieving minimal residual disease-negative status as a goal.
Montserrat E
J Clin Oncol; 2005 May; 23(13):2884-5. PubMed ID: 15738532
[No Abstract] [Full Text] [Related]
2. Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
Bosch F; Ferrer A; Villamor N; González M; Briones J; González-Barca E; Abella E; Gardella S; Escoda L; Pérez-Ceballos E; Asensi A; Sayas MJ; Font L; Altés A; Muntañola A; Bertazzoni P; Rozman M; Aymerich M; Giné E; Montserrat E
Clin Cancer Res; 2008 Jan; 14(1):155-61. PubMed ID: 18172266
[TBL] [Abstract][Full Text] [Related]
3. How to improve the treatment outcome in chronic lymphocytic leukemia?
Robak T
Leuk Res; 2010 Mar; 34(3):272-5. PubMed ID: 19682742
[No Abstract] [Full Text] [Related]
4. Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient.
Niscola P; Principe MI; Palombi M; Fratoni S; Piccioni D; Maurillo L; de Fabritiis P; Amadori S; Del Poeta G
Leuk Res; 2008 Feb; 32(2):363-5. PubMed ID: 17449094
[No Abstract] [Full Text] [Related]
5. [Progress in the treatment of chronic lymphocytic leukemia].
Pawelski S
Acta Haematol Pol; 1993; 24(1):5-12. PubMed ID: 8488737
[No Abstract] [Full Text] [Related]
6. Analysis of outcome by response flawed.
Anderson JR; Neuberg DS
J Clin Oncol; 2005 Nov; 23(31):8122-3; author reply 8123-4. PubMed ID: 16258114
[No Abstract] [Full Text] [Related]
7. Why R-CHOP for first line treatment of chronic lymphocytic leukemia?
Smolej L
Int J Lab Hematol; 2007 Dec; 29(6):478-9; author reply 479. PubMed ID: 17988306
[No Abstract] [Full Text] [Related]
8. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
Ahmadi T; Schuster SJ
J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
[No Abstract] [Full Text] [Related]
9. Frontline therapy for chronic lymphocytic leukemia: the dilemma continues.
Nabhan C
Clin Cancer Res; 2008 Jul; 14(13):4353. PubMed ID: 18594019
[No Abstract] [Full Text] [Related]
10. Autologous stem cell transplantation for chronic lymphocytic leukemia.
Dreger P; Brand R; Michallet M
Semin Hematol; 2007 Oct; 44(4):246-51. PubMed ID: 17961723
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?
Nabhan C; Coutré S; Hillmen P
Br J Haematol; 2007 Feb; 136(3):379-92. PubMed ID: 17129223
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A; Faderl S; Keating MJ
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
[TBL] [Abstract][Full Text] [Related]
13. Head and neck manifestations of B-cell chronic lymphocytic leukemia.
Cohen-Kerem R; Quitt M; Greenberg E; Braverman I
Otolaryngol Head Neck Surg; 2000 Dec; 123(6):784-5. PubMed ID: 11112980
[No Abstract] [Full Text] [Related]
14. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic leukemia masquerading as uveitis.
Gupta G; Larson RA; Jampol LM
Retina; 2007; 27(9):1311-2. PubMed ID: 18046244
[No Abstract] [Full Text] [Related]
16. [Allogeneic transplantation of the kidney in a patient with B-small cell lymphocytic lymphoma and chronic renal failure].
Biriukova LS; Dzhumabaeva BT; Daumova VB; Zvonkov EE; Kremenetskaia AM; Kaplanskaia IB; Varlamova EIu; Vorob'ev IA; Gretsov EM; Kravchenko SK; Moseshvili EG; Akhmetshin RB
Ter Arkh; 2006; 78(10):48-51. PubMed ID: 17180938
[No Abstract] [Full Text] [Related]
17. Benefits of minimal residual disease negativity in the therapy of chronic lymphocytic leukemia.
Kay NE
Clin Adv Hematol Oncol; 2008 Oct; 6(10):727-9. PubMed ID: 18997661
[No Abstract] [Full Text] [Related]
18. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
[TBL] [Abstract][Full Text] [Related]
19. Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia.
Giannopoulos K; Dmoszyńska A; Roliński J
Leuk Res; 2007 Mar; 31(3):411-2. PubMed ID: 16978694
[No Abstract] [Full Text] [Related]
20. Occurrence of trisomy 12, t(14;18)(q32;q21), and t(8;14)(q24.1;q11.2) in a patient with B-cell chronic lymphocytic leukemia.
Lau LC; Lim P; Lim YC; Teng LM; Lim TH; Lim LC; Tan SY; Lim ST; Sanger WG; Tien SL
Cancer Genet Cytogenet; 2008 Sep; 185(2):95-101. PubMed ID: 18722878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
